| Literature DB >> 32530771 |
Sean Wei Xiang Ong1,2, Shawn Vasoo1,2,3,4, Sapna P Sadarangani1,2,3, Lin Cui5, Kalisvar Marimuthu1,2,4, Poh Lian Lim1,2,3,4, Jing Wen Kong3,6, Judith Chui Ching Wong7,8, Kim Yoong Puong8, Kwai Peng Chan8,9.
Abstract
We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully. One patient was confirmed to have vaccine-associated rubella via sequencing of virus isolated in viral culture. The other patient had a pharyngeal swab positive for rubella virus PCR, with sequencing matching the vaccine strain. There are few reports of clinical disease from rubella vaccine-strains in the literature. Previous authors have reported severe disseminated vaccine-associated rubella in both immunodeficient and immunocompetent patients. Further study is required to ascertain the incidence, risk factors, and clinical characteristics of this condition; as well as investigate the extent of horizontal transmission to guide infection control recommendations.Entities:
Keywords: MMR; Rubella; genotyping; vaccine; vaccine strain
Year: 2020 PMID: 32530771 PMCID: PMC7872085 DOI: 10.1080/21645515.2020.1765623
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452